Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Shares Issued (2024 - 2025)

Xilio Therapeutics' Shares Issued history spans 2 years, with the latest figure at $35000.0 for Q2 2025.

  • For Q2 2025, Shares Issued rose 100.82% year-over-year to $35000.0; the TTM value through Sep 2025 reached $11000.0, changed N/A, while the annual FY2024 figure was $5000.0, 37.5% down from the prior year.
  • Shares Issued for Q2 2025 was $35000.0 at Xilio Therapeutics, up from $5000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $4.3 million in Q1 2024 and bottomed at -$4.3 million in Q2 2024.